
The CLEARTEST Cardio rapid / Infarction Test is a highly efficient rapid test for the early diagnosis of an acute myocardial infarction. Ideal for emergency situations, home visits, and infarction monitoring, it delivers initial results as early as 20 minutes after an infarction . With a detection limit of only 0.5 ng/ml, it is among the fastest biomarkers on the market. The test detects two crucial proteins – hFABP and troponin I – thus enabling immediate treatment decisions. Thanks to its ability to be stored at room temperature, it is particularly versatile.
Areas of application:
-
Emergency medicine and rescue service
-
General practitioner practices and mobile medical services
-
Clinical and hospital diagnostics
-
Monitoring after a heart attack (including reinfarction monitoring)
-
Cardiological diagnostics
Advantages at a glance:
-
Extremely fast diagnosis : Positive result just 20 minutes after heart attack
-
Two markers in one test : hFABP (earliest marker) & Troponin I (long-term detection)
-
High detection sensitivity : 0.5 ng/ml
-
Simple procedure : Only 1 drop of whole blood, serum or plasma
-
Fast evaluation : Results after 10 minutes
-
Room temperature storage – no refrigerated transport required
-
Ideal for emergencies and home visits
Further information:
-
hFABP: Earliest marker for myocardial damage, detectable as early as 20 minutes after the event, ideal for reinfarction monitoring on day 4.
-
Troponin I: Detectable in the blood from about 8 hours, for up to 8 days.
-
Comparison: Troponin T (manufacturer Roche) is only detectable after 3 hours and requires refrigeration.
-
Storing at room temperature facilitates transport and handling
Delivery information:
PZN: 13894068 - 13894074
WEEE number:
Assistive device number:
Manufacturer:
Servoprax GmbH
Am Marienbusch 9
46485 Wesel
Deutschland
Tel: +49 281 95283-05283-0
Email: info@servoprax.de
VAT ID number: DE120980351